GoodRx Holdings, Inc. (NASDAQ: GDRX) Stock Competitors & Peer Comparison
See GDRX's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GDRX and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GDRX | $3.68 | -1.08% | 1.3B | 11.50 | $0.32 | N/A |
| GEHC | $71.77 | +2.08% | 32.4B | 15.74 | $4.56 | +0.20% |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $62.43 | +3.02% | 12.3B | 50.35 | $1.24 | N/A |
| TEM | $52.05 | +12.86% | 9.1B | -104.10 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $104.63 | +1.15% | 8.7B | 24.45 | $4.28 | N/A |
| HNGE | $89.33 | +11.55% | 6.9B | 47.81 | $1.87 | N/A |
| TXG | $52.03 | +14.10% | 6.6B | -306.06 | -$0.17 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
GDRX vs GEHC Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, GEHC has a market cap of 32.4B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while GEHC trades at $71.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas GEHC's P/E ratio is 15.74. In terms of profitability, GDRX's ROE is +0.03%, compared to GEHC's ROE of +0.15%. Regarding short-term risk, GDRX is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check GEHC's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
GDRX vs GEHCV Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas GEHCV's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, GDRX is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
GDRX vs BTSG Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, BTSG has a market cap of 12.3B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while BTSG trades at $62.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas BTSG's P/E ratio is 50.35. In terms of profitability, GDRX's ROE is +0.03%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, GDRX is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check BTSG's competition here
Tempus AI, Inc. (NASDAQ: TEM)
GDRX vs TEM Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, TEM has a market cap of 9.1B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while TEM trades at $52.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas TEM's P/E ratio is -104.10. In terms of profitability, GDRX's ROE is +0.03%, compared to TEM's ROE of -0.55%. Regarding short-term risk, GDRX is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
GDRX vs SGFY Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SGFY's P/E ratio is 70.91. In terms of profitability, GDRX's ROE is +0.03%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, GDRX is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
GDRX vs HQY Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, HQY has a market cap of 8.7B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while HQY trades at $104.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas HQY's P/E ratio is 24.45. In terms of profitability, GDRX's ROE is +0.03%, compared to HQY's ROE of +0.11%. Regarding short-term risk, GDRX is more volatile compared to HQY. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check HQY's competition here
Hinge Health, Inc. (NYSE: HNGE)
GDRX vs HNGE Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, HNGE has a market cap of 6.9B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while HNGE trades at $89.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas HNGE's P/E ratio is 47.81. In terms of profitability, GDRX's ROE is +0.03%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, GDRX is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check HNGE's competition here
10x Genomics, Inc. (NASDAQ: TXG)
GDRX vs TXG Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, TXG has a market cap of 6.6B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while TXG trades at $52.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas TXG's P/E ratio is -306.06. In terms of profitability, GDRX's ROE is +0.03%, compared to TXG's ROE of -0.09%. Regarding short-term risk, GDRX is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check TXG's competition here
R1 RCM Inc. (NASDAQ: RCM)
GDRX vs RCM Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas RCM's P/E ratio is -102.21. In terms of profitability, GDRX's ROE is +0.03%, compared to RCM's ROE of +0.00%. Regarding short-term risk, GDRX is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check RCM's competition here
Doximity, Inc. (NYSE: DOCS)
GDRX vs DOCS Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, DOCS has a market cap of 5.1B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while DOCS trades at $27.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas DOCS's P/E ratio is 17.91. In terms of profitability, GDRX's ROE is +0.03%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, GDRX is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check DOCS's competition here
Waystar Holding Corp. (NASDAQ: WAY)
GDRX vs WAY Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, WAY has a market cap of 4.6B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while WAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas WAY's P/E ratio is 16.05. In terms of profitability, GDRX's ROE is +0.03%, compared to WAY's ROE of +0.04%. Regarding short-term risk, GDRX is more volatile compared to WAY. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check WAY's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
GDRX vs ONEM Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ONEM's P/E ratio is -7.77. In terms of profitability, GDRX's ROE is +0.03%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, GDRX is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
GDRX vs PRVA Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, PRVA has a market cap of 2.8B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while PRVA trades at $22.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas PRVA's P/E ratio is 106.90. In terms of profitability, GDRX's ROE is +0.03%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, GDRX is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check PRVA's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
GDRX vs HTFL Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, HTFL has a market cap of 2.5B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while HTFL trades at $28.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas HTFL's P/E ratio is -14.34. In terms of profitability, GDRX's ROE is +0.03%, compared to HTFL's ROE of +8.30%. Regarding short-term risk, GDRX is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check HTFL's competition here
GeneDx Holdings Corp. (NASDAQ: WGS)
GDRX vs WGS Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, WGS has a market cap of 2.3B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while WGS trades at $77.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas WGS's P/E ratio is 214.11. In terms of profitability, GDRX's ROE is +0.03%, compared to WGS's ROE of -0.39%. Regarding short-term risk, GDRX is less volatile compared to WGS. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check WGS's competition here
Progyny, Inc. (NASDAQ: PGNY)
GDRX vs PGNY Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, PGNY has a market cap of 2.2B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while PGNY trades at $28.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas PGNY's P/E ratio is 20.36. In terms of profitability, GDRX's ROE is +0.03%, compared to PGNY's ROE of +0.16%. Regarding short-term risk, GDRX is less volatile compared to PGNY. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check PGNY's competition here
GeneDx Holdings Corp. (NASDAQ: WGSWW)
GDRX vs WGSWW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, WGSWW has a market cap of 1.8B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while WGSWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas WGSWW's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to WGSWW's ROE of -0.39%. Regarding short-term risk, GDRX is more volatile compared to WGSWW. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check WGSWW's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
GDRX vs NXGN Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas NXGN's P/E ratio is -266.00. In terms of profitability, GDRX's ROE is +0.03%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, GDRX is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check NXGN's competition here
Omada Health (NASDAQ: OMDA)
GDRX vs OMDA Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, OMDA has a market cap of 1.4B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while OMDA trades at $23.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas OMDA's P/E ratio is 338.14. In terms of profitability, GDRX's ROE is +0.03%, compared to OMDA's ROE of +0.02%. Regarding short-term risk, GDRX is less volatile compared to OMDA. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check OMDA's competition here
Agiliti, Inc. (NYSE: AGTI)
GDRX vs AGTI Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas AGTI's P/E ratio is -71.79. In terms of profitability, GDRX's ROE is +0.03%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, GDRX is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check AGTI's competition here
Teladoc Health, Inc. (NYSE: TDOC)
GDRX vs TDOC Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, TDOC has a market cap of 1.3B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while TDOC trades at $7.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas TDOC's P/E ratio is -7.92. In terms of profitability, GDRX's ROE is +0.03%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, GDRX is less volatile compared to TDOC. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check TDOC's competition here
Certara, Inc. (NASDAQ: CERT)
GDRX vs CERT Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CERT trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CERT's P/E ratio is 20.50. In terms of profitability, GDRX's ROE is +0.03%, compared to CERT's ROE of -0.07%. Regarding short-term risk, GDRX is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CERT's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
GDRX vs CCLDO Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CCLDO's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, GDRX is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CCLDO's competition here
HealthStream, Inc. (NASDAQ: HSTM)
GDRX vs HSTM Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, HSTM has a market cap of 839.1M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while HSTM trades at $28.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas HSTM's P/E ratio is 35.46. In terms of profitability, GDRX's ROE is +0.03%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, GDRX is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check HSTM's competition here
Phreesia, Inc. (NYSE: PHR)
GDRX vs PHR Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, PHR has a market cap of 773M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while PHR trades at $12.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas PHR's P/E ratio is 44.66. In terms of profitability, GDRX's ROE is +0.03%, compared to PHR's ROE of +0.03%. Regarding short-term risk, GDRX is more volatile compared to PHR. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check PHR's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
GDRX vs MPLN-WT Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, GDRX is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
GDRX vs ACCD Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ACCD's P/E ratio is -3.08. In terms of profitability, GDRX's ROE is +0.03%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, GDRX is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check ACCD's competition here
Claritev Corporation (NYSE: CTEV)
GDRX vs CTEV Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CTEV has a market cap of 546.7M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CTEV trades at $32.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CTEV's P/E ratio is -2.46. In terms of profitability, GDRX's ROE is +0.03%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, GDRX is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check CTEV's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
GDRX vs SOPH Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SOPH has a market cap of 537.5M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SOPH trades at $7.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SOPH's P/E ratio is -6.95. In terms of profitability, GDRX's ROE is +0.03%, compared to SOPH's ROE of -1.41%. Regarding short-term risk, GDRX is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check SOPH's competition here
Sharecare, Inc. (NASDAQ: SHCR)
GDRX vs SHCR Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SHCR's P/E ratio is -3.76. In terms of profitability, GDRX's ROE is +0.03%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, GDRX is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check SHCR's competition here
NRC Health (NASDAQ: NRC)
GDRX vs NRC Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, NRC has a market cap of 458.4M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while NRC trades at $20.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas NRC's P/E ratio is 24.80. In terms of profitability, GDRX's ROE is +0.03%, compared to NRC's ROE of +0.48%. Regarding short-term risk, GDRX is less volatile compared to NRC. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check NRC's competition here
Evolent Health, Inc. (NYSE: EVH)
GDRX vs EVH Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, EVH has a market cap of 446M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while EVH trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas EVH's P/E ratio is 30.50. In terms of profitability, GDRX's ROE is +0.03%, compared to EVH's ROE of -0.99%. Regarding short-term risk, GDRX is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check EVH's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
GDRX vs SLGCW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, GDRX's ROE is +0.03%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, GDRX is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
GDRX vs SLGC Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SLGC's P/E ratio is -3.04. In terms of profitability, GDRX's ROE is +0.03%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, GDRX is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
GDRX vs TBRG Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas TBRG's P/E ratio is 9.37. In terms of profitability, GDRX's ROE is +0.03%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, GDRX is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
GDRX vs MPLN Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MPLN's P/E ratio is -0.23. In terms of profitability, GDRX's ROE is +0.03%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, GDRX is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
GDRX vs SY Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SY has a market cap of 286M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SY trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SY's P/E ratio is -6.61. In terms of profitability, GDRX's ROE is +0.03%, compared to SY's ROE of -0.16%. Regarding short-term risk, GDRX is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
GDRX vs TRHC Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas TRHC's P/E ratio is -4.27. In terms of profitability, GDRX's ROE is +0.03%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, GDRX is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
GDRX vs SMFR Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SMFR's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, GDRX is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
GDRX vs SPOK Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SPOK has a market cap of 240.6M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SPOK trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SPOK's P/E ratio is 19.20. In terms of profitability, GDRX's ROE is +0.03%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, GDRX is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
GDRX vs AMWL Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, AMWL has a market cap of 228.6M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while AMWL trades at $13.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas AMWL's P/E ratio is -3.04. In terms of profitability, GDRX's ROE is +0.03%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, GDRX is less volatile compared to AMWL. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check AMWL's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
GDRX vs CPSI Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CPSI's P/E ratio is -183.80. In terms of profitability, GDRX's ROE is +0.03%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, GDRX is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check CPSI's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
GDRX vs OPRX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, OPRX has a market cap of 132.9M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while OPRX trades at $7.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas OPRX's P/E ratio is 6.50. In terms of profitability, GDRX's ROE is +0.03%, compared to OPRX's ROE of +0.05%. Regarding short-term risk, GDRX is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check OPRX's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
GDRX vs HCAT Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, HCAT has a market cap of 127.8M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while HCAT trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas HCAT's P/E ratio is 8.65. In terms of profitability, GDRX's ROE is +0.03%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, GDRX is less volatile compared to HCAT. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
GDRX vs AUGX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas AUGX's P/E ratio is -4.99. In terms of profitability, GDRX's ROE is +0.03%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, GDRX is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
GDRX vs CCLD Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CCLD has a market cap of 111.8M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CCLD trades at $2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CCLD's P/E ratio is 10.12. In terms of profitability, GDRX's ROE is +0.03%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, GDRX is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check CCLD's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
GDRX vs DH Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, DH has a market cap of 75.3M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while DH trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas DH's P/E ratio is 2.74. In terms of profitability, GDRX's ROE is +0.03%, compared to DH's ROE of -0.67%. Regarding short-term risk, GDRX is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check DH's competition here
SCWorx Corp. (NASDAQ: WORX)
GDRX vs WORX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, WORX has a market cap of 72.8M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while WORX trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas WORX's P/E ratio is -5.29. In terms of profitability, GDRX's ROE is +0.03%, compared to WORX's ROE of -0.65%. Regarding short-term risk, GDRX is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check WORX's competition here
Forian Inc. (NASDAQ: FORA)
GDRX vs FORA Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas FORA's P/E ratio is -24.11. In terms of profitability, GDRX's ROE is +0.03%, compared to FORA's ROE of -0.17%. Regarding short-term risk, GDRX is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
GDRX vs CCLDP Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CCLDP's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, GDRX is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CCLDP's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
GDRX vs ONMDW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ONMDW has a market cap of 37M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ONMDW trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ONMDW's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to ONMDW's ROE of +0.90%. Regarding short-term risk, GDRX is more volatile compared to ONMDW. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check ONMDW's competition here
OneMedNet Corporation (NASDAQ: ONMD)
GDRX vs ONMD Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ONMD has a market cap of 35.6M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ONMD trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ONMD's P/E ratio is -4.16. In terms of profitability, GDRX's ROE is +0.03%, compared to ONMD's ROE of +0.90%. Regarding short-term risk, GDRX is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check ONMD's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
GDRX vs SNCE Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SNCE's P/E ratio is -0.27. In terms of profitability, GDRX's ROE is +0.03%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, GDRX is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
GDRX vs AKLI Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas AKLI's P/E ratio is -0.71. In terms of profitability, GDRX's ROE is +0.03%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, GDRX is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
GDRX vs SHLT Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SHLT's P/E ratio is -3.87. In terms of profitability, GDRX's ROE is +0.03%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, GDRX is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check SHLT's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
GDRX vs SHCRW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, GDRX's ROE is +0.03%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, GDRX is more volatile compared to SHCRW. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check SHCRW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
GDRX vs STRM Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas STRM's P/E ratio is -2.40. In terms of profitability, GDRX's ROE is +0.03%, compared to STRM's ROE of -0.65%. Regarding short-term risk, GDRX is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
GDRX vs RNLX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas RNLX's P/E ratio is -0.33. In terms of profitability, GDRX's ROE is +0.03%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, GDRX is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
GDRX vs LIFW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas LIFW's P/E ratio is -0.02. In terms of profitability, GDRX's ROE is +0.03%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, GDRX is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
GDRX vs BBLN Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas BBLN's P/E ratio is -0.04. In terms of profitability, GDRX's ROE is +0.03%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, GDRX is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check BBLN's competition here
HeartBeam, Inc. (NASDAQ: BEATW)
GDRX vs BEATW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, BEATW has a market cap of 11.7M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while BEATW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas BEATW's P/E ratio is -0.03. In terms of profitability, GDRX's ROE is +0.03%, compared to BEATW's ROE of -10.34%. Regarding short-term risk, GDRX is more volatile compared to BEATW. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check BEATW's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
GDRX vs ETAO Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ETAO's P/E ratio is -0.01. In terms of profitability, GDRX's ROE is +0.03%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, GDRX is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
GDRX vs MGRX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MGRX has a market cap of 8.3M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MGRX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MGRX's P/E ratio is -0.36. In terms of profitability, GDRX's ROE is +0.03%, compared to MGRX's ROE of -1.21%. Regarding short-term risk, GDRX is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check MGRX's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
GDRX vs BFRG Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, BFRG has a market cap of 6.9M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while BFRG trades at $0.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas BFRG's P/E ratio is -1.09. In terms of profitability, GDRX's ROE is +0.03%, compared to BFRG's ROE of -2.18%. Regarding short-term risk, GDRX is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check BFRG's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
GDRX vs SCNX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SCNX has a market cap of 5.9M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SCNX trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SCNX's P/E ratio is -0.15. In terms of profitability, GDRX's ROE is +0.03%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, GDRX is more volatile compared to SCNX. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check SCNX's competition here
UpHealth, Inc. (NYSE: UPH)
GDRX vs UPH Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas UPH's P/E ratio is -0.07. In terms of profitability, GDRX's ROE is +0.03%, compared to UPH's ROE of -1.05%. Regarding short-term risk, GDRX is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check UPH's competition here
UpHealth, Inc. (NYSE: UPH-WT)
GDRX vs UPH-WT Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, GDRX is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check UPH-WT's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
GDRX vs PEARW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas PEARW's P/E ratio is -0.00. In terms of profitability, GDRX's ROE is +0.03%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, GDRX is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check PEARW's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
GDRX vs PEAR Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas PEAR's P/E ratio is -0.08. In terms of profitability, GDRX's ROE is +0.03%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, GDRX is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check PEAR's competition here
Ontrak, Inc. (NASDAQ: OTRK)
GDRX vs OTRK Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas OTRK's P/E ratio is -0.02. In terms of profitability, GDRX's ROE is +0.03%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, GDRX is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
GDRX vs CMAX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CMAX's P/E ratio is -0.00. In terms of profitability, GDRX's ROE is +0.03%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, GDRX is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CMAX's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
GDRX vs HCTI Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, HCTI has a market cap of 1.4M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while HCTI trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas HCTI's P/E ratio is -0.16. In terms of profitability, GDRX's ROE is +0.03%, compared to HCTI's ROE of -0.68%. Regarding short-term risk, GDRX is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
GDRX vs VSEEW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, VSEEW has a market cap of 1.4M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, GDRX's ROE is +0.03%, compared to VSEEW's ROE of -115.71%. Regarding short-term risk, GDRX is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
GDRX vs LIFWZ Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, GDRX is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check LIFWZ's competition here
Aclarion, Inc. (NASDAQ: ACON)
GDRX vs ACON Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ACON has a market cap of 1.2M. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ACON trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ACON's P/E ratio is -0.25. In terms of profitability, GDRX's ROE is +0.03%, compared to ACON's ROE of -0.59%. Regarding short-term risk, GDRX is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check ACON's competition here
EUDA Health Holdings Limited (NASDAQ: EUDAW)
GDRX vs EUDAW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, EUDAW has a market cap of 952.7K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while EUDAW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas EUDAW's P/E ratio is 0.03. In terms of profitability, GDRX's ROE is +0.03%, compared to EUDAW's ROE of +1.20%. Regarding short-term risk, GDRX is less volatile compared to EUDAW. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check EUDAW's competition here
VSee Health, Inc. (NASDAQ: VSEE)
GDRX vs VSEE Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, VSEE has a market cap of 816.5K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while VSEE trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas VSEE's P/E ratio is -0.10. In terms of profitability, GDRX's ROE is +0.03%, compared to VSEE's ROE of -115.71%. Regarding short-term risk, GDRX is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check VSEE's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
GDRX vs MSPRZ Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, GDRX is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check MSPRZ's competition here
Akerna Corp. (NASDAQ: KERN)
GDRX vs KERN Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas KERN's P/E ratio is -0.01. In terms of profitability, GDRX's ROE is +0.03%, compared to KERN's ROE of -0.20%. Regarding short-term risk, GDRX is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check KERN's competition here
Akerna Corp. (NASDAQ: KERNW)
GDRX vs KERNW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas KERNW's P/E ratio is -0.00. In terms of profitability, GDRX's ROE is +0.03%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, GDRX is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check KERNW's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
GDRX vs LIFWW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas LIFWW's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, GDRX is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check LIFWW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
GDRX vs ZCMD Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ZCMD has a market cap of 37.5K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ZCMD trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ZCMD's P/E ratio is -0.04. In terms of profitability, GDRX's ROE is +0.03%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, GDRX is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check ZCMD's competition here
CareMax, Inc. (NASDAQ: CMAXW)
GDRX vs CMAXW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CMAXW's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, GDRX is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CMAXW's competition here
Aclarion, Inc. (NASDAQ: ACONW)
GDRX vs ACONW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, ACONW has a market cap of 13.2K. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while ACONW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas ACONW's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, GDRX is less volatile compared to ACONW. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check ACONW's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
GDRX vs CHNG Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CHNG's P/E ratio is -152.72. In terms of profitability, GDRX's ROE is +0.03%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, GDRX is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CHNG's competition here
CareCloud, Inc. (NASDAQ: MTBC)
GDRX vs MTBC Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MTBC's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, GDRX is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check MTBC's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
GDRX vs KURIU Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas KURIU's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, GDRX is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check KURIU's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
GDRX vs CNVY Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CNVY's P/E ratio is -71.50. In terms of profitability, GDRX's ROE is +0.03%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, GDRX is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CNVY's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
GDRX vs MSPRV Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MSPRV's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to MSPRV's ROE of N/A. Regarding short-term risk, GDRX is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check MSPRV's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
GDRX vs MTBCP Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MTBCP's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, GDRX is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check MTBCP's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
GDRX vs SMFRW Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas SMFRW's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, GDRX is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check SMFRW's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
GDRX vs IMS Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, IMS has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas IMS's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to IMS's ROE of +0.27%. Regarding short-term risk, GDRX is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check IMS's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
GDRX vs NAVA Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas NAVA's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, GDRX is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for GDRX.Check NAVA's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
GDRX vs AFFX Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas AFFX's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, GDRX is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check AFFX's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
GDRX vs CHNGU Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CHNGU's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, GDRX is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CHNGU's competition here
NantHealth, Inc. (NASDAQ: NH)
GDRX vs NH Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, NH has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas NH's P/E ratio is -0.12. In terms of profitability, GDRX's ROE is +0.03%, compared to NH's ROE of +0.35%. Regarding short-term risk, GDRX is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for GDRX.Check NH's competition here
Castlight Health, Inc. (NYSE: CSLT)
GDRX vs CSLT Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CSLT's P/E ratio is -37.27. In terms of profitability, GDRX's ROE is +0.03%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, GDRX is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CSLT's competition here
Cerner Corporation (NASDAQ: CERN)
GDRX vs CERN Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, CERN has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas CERN's P/E ratio is 55.84. In terms of profitability, GDRX's ROE is +0.03%, compared to CERN's ROE of +0.14%. Regarding short-term risk, GDRX is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check CERN's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
GDRX vs MTBCO Comparison August 2026
GoodRx Holdings, Inc. (NASDAQ: GDRX) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GDRX stands at 1.3B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, GDRX is priced at $3.68 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GDRX currently has a P/E ratio of 11.50, whereas MTBCO's P/E ratio is N/A. In terms of profitability, GDRX's ROE is +0.03%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, GDRX is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for GDRX.Check MTBCO's competition here